Recent studies reveal that high body mass index is now driving more deaths and disability worldwide than ever before, with projections indicating a dramatic rise in diabetes prevalence by 2050, highlighting the urgent need for enhanced prevention and systemic intervention.
The global toll of excess body weight has risen sharply over the past three decades, and the latest analysis drawn from the Global Burden of Disease Study 2021 shows that high body mass index is now driving more deaths and disability than ever before. The study defines high BMI as above 25 kg/m² in adults aged 20 and older and finds that deaths and disability-adjusted life years linked to it more than doubled between 1990 and 2021 for both women and men. Diabetes remains the leading condition tied to that burden, followed by ischaemic heart disease, hypertensive heart disease, chronic kidney disease, low back pain and stroke.
That pattern tracks closely with the global diabetes epidemic itself. A separate Global Burden of Disease analysis published in The Lancet estimated that 529 million people were living with diabetes in 2021, with an age-standardised prevalence of 6.1%. The highest rates were in North Africa and the Middle East, where prevalence reached 9.3%, underscoring how closely the region’s diabetes crisis is linked to rising obesity and broader dietary change.
The outlook is worse still if current trends continue. The Lancet study projects that by 2050 more than 1.31 billion people will have diabetes worldwide, with age-standardised prevalence in North Africa and the Middle East expected to exceed 10%. Other recent burden studies point in the same direction, including research showing that chronic kidney disease attributable to high BMI has more than tripled over time, adding further pressure to health systems already struggling with long-term complications of metabolic disease.
Taken together, the evidence points to a need for sustained surveillance, earlier prevention and stronger population-level action on weight, diet and physical activity. The global rise in high-BMI-related disease is not just a clinical issue but a policy one, with implications for screening, treatment costs and the design of food and transport systems. Without broader intervention, the burden on diabetes services is likely to deepen well beyond the next generation.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
